Genenta Science SPA

GNTA · NASDAQ

$0.63+$0.00 (+0.00%)TodayMarket closed · Oct 23, 4:01 PM ET

Prev close $0.63

About GNTA

Genenta Science SpA is an early-stage company, which engages in the development of first-in-class cell and gene cancer therapies. The company is headquartered in Milan, Milano and currently employs 9 full-time employees. The company went IPO on 2021-12-15. The firm focuses on the development of lentivirus-based gene and cell therapies in cancer. The company uses gene-based cytokine delivery to activate the immune system within the tumor providing the anti-tumor response. The firm not only operates locally but also is present in global markets, including the United States.

Employees: 9
Headquarters: Milan, Milano
Listed: Dec 15, 2021
Sector: Health Care
Industry: Biotechnology
Website: genenta.com

Leadership

Genenta Science SPA executives
Name	Title	Since	Age
Pierluigi Paracchi	—	2014	51
Richard Slansky	—	—	67
Barbara Regonini	—	—	52
Stefania Mazzoleni	—	—	42
Carlo Russo	—	—	72
John Louis Cantello	—	—	59
Lauren Haeyong Chung	—	—	52
Armon Reza Sharei	—	—	37
Todd Wider	—	—	60

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.